The PulmoRounds 2025 are coming to the Netherlands. The PulmoRounds is a series of educational events taking place across Scandinavia and the Benelux countries. The events bring together physicians treating severe asthma and COPD patients. It entails scientific exchange and discussion on clinical challenges with two international key opinion leaders in the respiratory field.

CHRONIC-OBSTRUCTIVE-PULMONARY-DISEASE-(COPD)

RESPIRATORY

The educational programme focuses on:
<ul>
 <li>Asthma:&nbsp;Decoding the natural history of the disease, including mucus plugging and airway remodeling and addressing key pressure points in clinical management of severe asthma today.</li>
 <li>COPD:&nbsp;Exploring inflammation, biomarkers, and eosinophil (EOS) measurements to optimize precision treatment using biologics.</li>
</ul>

The initiative aligns with the growing demand for expert-led, real-world guidance to improve patient outcomes in chronic respiratory diseases. The PulmoRounds aim to empower healthcare providers with actionable insights to enhance patient care.

The educational programme brings expert knowledge directly to healthcare providers through a structured and well-demonstrated setup. This includes:
<ul>
 <li>Interactive lectures tailored to local clinical practice.</li>
 <li>Case discussion to bridge theory and practice.</li>
</ul>

This event is organised by Sanofi-Regeneron. All hospitality provided is fully compliant with CGR guidelines.

Date: Wednesday the 3rd of December 2025

Time: 18.00 CET

Location: On-site from PAUSHUIZE Kromme Nieuwegracht 49, Utrecht

<figure class="table" style="width:100%;">
 <table style="background-color:#F4F2F6;">
 <tbody>
 <tr>
 <td style="border:1px solid #c9c9c9;width:25%;">18.00 - 18.20</td>
 <td style="border:1px solid #c9c9c9;width:75%;">
 <h4>Welcome and Introduction</h4>
 Type II Inflammatory Diseases (Asthma &amp; COPD)
 By Dr. Hans in't Veen (NL)</td>
 </tr>
 <tr>
 <td style="border:1px solid #c9c9c9;width:25%;">18.20 – 19.00</td>
 <td style="border:1px solid #c9c9c9;width:75%;">
 <h4>Breathing New Life into COPD</h4>
 Understanding Inflammation Types, Biomarkers, EOS Measurement, and the Role of Biologics in COPD
 By Prof. Dr. Dave Singh (UK)</td>
 </tr>
 <tr>
 <td style="border:1px solid #c9c9c9;width:25%;">19.00 – 19.15</td>
 <td style="border:1px solid #c9c9c9;width:75%;">
 <h4>Break</h4></td>
 </tr>
 <tr>
 <td style="border:1px solid #c9c9c9;width:25%;">19.15 – 19.55</td>
 <td style="border:1px solid #c9c9c9;width:75%;">
 <h4>Asthma Unplugged</h4>
 Exploring Mucus Plugging, Airway Remodeling in Asthma and Insights from Real-World Data
 By Prof. Dr. Alberto Papi (IT)</td>
 </tr>
 <tr>
 <td style="border:1px solid #c9c9c9;width:25%;">19.55 - 20.25</td>
 <td style="border:1px solid #c9c9c9;width:75%;">
 <h4>Q&amp;A and panel discussion</h4>
 By Dr. Hans in 't Veen (NL), Prof. Dave Singh (UK), and Prof. Alberto Papi (IT)</td>
 </tr>
 </tbody>
 </table>
</figure>

Dr. Hans in't Veen 
 Researcher at Franciscus Gasthuis &amp; Vlietland, NL

Prof. Dave Singh 
 Professor of Clinical Pharmacology and Respiratory Medicine at the University of Manchester, UK

Prof. Dr. Alberto Papi 
 Professor of Respiratory Medicine at the University of Ferrara, 
 Italy

Alberto Papi is Professor of Respiratory Medicine at the University of Ferrara, Italy, and Director of the Respiratory Unit of the Department of CardioThoracic Medicine, S. Anna University Hospital, Ferrara, Italy.
Professor Papi trained in Respiratory Medicine at the University of Parma, and spent 4 years in the UK as a Clinical Research Fellow at the University of Southampton, where he is an Honorary Clinical Lecturer. In 2015, he was made a Fellow of the European Respiratory Society. He is Member of the GOLD Science Committee.
Professor Papi’s principal field of research is airway inflammation in asthma and COPD, its molecular mechanisms and pharmacological modulation. In his studies, he has taken particular interest in the role of respiratory viral infections in stable/exacerbated obstructive lung diseases, and the underlying molecular and immunological mechanisms. He has coordinated several studies, particularly in asthma and COPD, and he has given presentations at national and international meetings. He has published more than 600 articles in peer-reviewed journals (including NEJM, Lancet, Lancet Respiratory Medicine, AJRCCM), and several other publications in non-peer-reviewed journals. H Index 103.

Biography&nbsp;Prof. Dr. Papi

After graduating in Medicine from Cambridge University, I trained in respiratory medicine and clinical pharmacology. This included an industrial placement for phase 1 experience. I completed an MD at the University of Manchester, and then was appointed as senior lecturer in respiratory pharmacology based in the University Hospital of South Manchester in 2003. My research interests are the pharmacotherapy of Asthma and COPD with studies spanning from basic pharmacology investigations of anti-inflammatory drug action to clinical trials. I am medical director of the Medicines Evaluation Unit performing proof of concept studies in obstructive lung diseases.

Biography&nbsp;Prof. Dave Singh

Heeft u vragen of wilt u meer weten? Wij zorgen dat u zo snel mogelijk geholpen wordt.

Wij staan klaar

PulmoRounds 2025

Voor uw intercontext, meld u aan bij uw account Sanofi Campus. Geef uw e-mail door aan uw e-mail.

Als u onze eerste e-mail op {email} tot bevestig uw account u kunt hieronder een nieuwe aanvragen. Als je het niet ziet, moet je mogelijk je spammap controleren.

Deze informatie wordt alleen gebruikt om uw account te valideren en wordt niet verspreid.

titel

Title

This website is for healthcare professionals only.

Welcome to BP Sanofi Campus

Create new password

Om u een gepersonaliseerde ervaring te bieden, moet u

Je profiel is onvolledig

De ADCT geeft een indicatie van hoe gecontroleerd het eczeem is. Beantwoord deze 6 eenvoudige vragen met uw patiënt om de ADCT-score te vinden. Het zal de juiste handelwijze aangeven.

Atopische dermatitis, een vorm van eczeem, kan het leven van uw patiënt op meer manieren beïnvloeden dan u weet.

Doe de atopische dermatitis controle test (ADCT)

Geniet van meer exclusieve inhoud{newline}door <a>door u vandaag te registreren</a>

Heb je al een account? <a>Hier inloggen</a>

Best practices voor het optimaliseren van de patiëntenzorg

Krijg een aangepast beeld van de onderwerpen waarin u geïnteresseerd bent, samen met de mogelijkheid om inhoud op te slaan om op een later tijdstip te bekijken of te lezen.

Onbeperkte toegang tot eersteklas inhoud, whitepapers, casestudy's, onderzoekspapers, webinars, training en up-to-date wetenschappelijke medische bronnen.

Gepersonaliseerde inhoud op basis van uw interessegebieden

Maak contact en blijf up-to-date met collega's op uw vakgebied en onderwerpen die u interesseren via gratis evenementen en leidinggevende forums.

Registreer om het volledige artikel te lezen.

Wij respecteren uw privacy en zullen uw informatie niet delen met derden.

Actuele gidsen die speciaal voor patiënten zijn geschreven

Onbeperkte toegang tot de nieuwste patiëntengidsen en bronnen. Deel inhoud met uw patiënten met gebruiksvriendelijke online tools.

Please complete your profile to read the content.

Your profile is not validated yet. Please verify your inbox.

Beperkte toegang

We can't find the page you're looking for

You are going to a website that is not operated by Sanofi. Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. Please ensure that you read the legal and privacy policy sections of any third-party site to which you link.

You are about to leave Sanofi Campus website.

You are now leaving this site to visit a partner website.

Thank you for visiting COPD Sanofi Campus.

Welcome to COPD Sanofi Campus.

Welcome to COPD Sanofi Campus

Welcome to CSU Sanofi Campus

Please refresh the page to access the content

Sorry, something went wrong

Normaal gesproken bieden we een schat aan kenis, maar we konden niet vinden waar je naar op zoek bent.

We konden niet vinden wat je zocht

Sanofi is niet verantwoordelijk voor de inhoud van deze externe website.

U staat op het punt Campus.sanofi/nl te verlaten.

Images from <a>iStockphoto.com</a>, Fotolia.de, <c>gettyimages.de</c>, <d>pexels.com</d> and <e>photocase.de</e> were used for our websites.

Volg ons:

Thank you for registering. Before we get started, we need to confirm your email address to ensure that we have the correct information.

Please follow these steps to complete your registration:

Would you like to receive future text messages about Beyfortus updates?

Sanofi is here to help support your patients, their families, and caregivers. For more information regarding Beyfortus® (nirsevimab-alip), call <a.callPhoneNumberBeyfortus>1-855-BEYFORTUS (1-855-239-3678)</a.callPhoneNumberBeyfortus> or sign up below to receive the latest updates via email or text. All fields are required.

Would you like to learn more about Beyfortus® (nirsevimab-alip) 50 mg and 100 mg injection? Leave us your contact details, and a Sanofi representative will be in touch. All fields are required.

Would you also like to receive future messages and updates about Beyfortus?

Do you want to participate in the Beyfortus Reservation Program?

What information are you interested in learning more about? (Optional)

Are you enrolled in CENRIFKI REMS?

Request a visit from your local ALPROLIX representative to learn more. Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Request a visit from your local ALTUVIIIO representative to learn more. Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Request a visit from your local QFITLIA representative to learn more. Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Sign up to schedule an office visit with your ALPROLIX® Representative or receive updates about ALPROLIX. Please complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Sign up to schedule an office visit with your local Sanofi representative and/or to receive updates about Qfitlia. Please complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required (unless otherwise specified).

All fields are required. (unless otherwise specified)

Sanofi biedt u exclusieve content over onze verschillende therapeutische gebieden op één portal speciaal voor professionals in de gezondheidszorg, inclusief wetenschappelijk nieuws, een lijst met evenementen en tools en diensten voor uw dagelijkse praktijk.

Bevestig uw status

Welcome to ITP Sanofi Campus

De inhoud van deze website is alleen toegankelijk voor geregistreerde gebruikers.

Log in alstublieft

Email verificatie

U ziet een voorbeeld van de portal. Wis uw cookies (bijvoorbeeld door uw browservenster te sluiten) om terug te gaan naar de openbare modus.

We hebben onze privacyverklaring bijgewerkt om je gegevens beter te beschermen en je ervaring te verbeteren. Neem even de tijd om de wijzigingen door te nemen door <privacyNewTab>hier te klikken</privacyNewTab>. Uw privacy is belangrijk voor ons. Klik op doorgaan om te bevestigen dat u de nieuwe privacyverklaring hebt gelezen.

Update van de privacyverklaring

Communicatie toestemming

My consents

Password

Confirm password

{resultsCount, plural, one {resultaat} other {resultaten}}

Log in om toegang te krijgen tot de resultaten

U moet inloggen op uw account om toegang te krijgen tot medische inhoud.

Inloggen

Registreer in minder dan 1 minuut om toegang te krijgen tot de resultaten

U verlaat nu het Sanofi inhoudsgedeelte van onze site en komt in het inhoudsgedeelte voor extern medisch bibliografisch zoeken.

U verlaat nu het externe medische bibliografische zoekgedeelte van onze site en komt in het inhoudsgedeelte van Sanofi.